• 1
    Kikuta H, Taguchi Y, Tomizawa K et al. Epstein–Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988; 333: 4557.
  • 2
    Jones JF, Shurin S, Abramowsky C et al. T-cell lymphomas containing Epstein–Barr viral DNA in patients with chronic Epstein–Barr virus infections. N Engl J Med 1988; 318: 73341.
  • 3
    Harabuchi Y, Yamanaka N, Kataura A et al. Epstein–Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 12830.
  • 4
    Ho FC, Srivastava G, Loke SL et al. Presence of Epstein–Barr virus DNA in nasal lymphomas of B- and T-cell type. Hematol Oncol 1990; 8: 27181.
  • 5
    Zhang Y, Nagata H, Ikeuchi T et al. Common cytological and cytogenetic features of Epstein–Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol 2003; 121: 80514.
  • 6
    Wong KF, Zhang YM, Chan JK. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia − is there a consistent pattern? Leuk Lymphoma 1999; 34: 24150.
  • 7
    Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3: 15568.
  • 8
    Tibbetts RS, Cortez D, Brumbaugh KM et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 2000; 14: 29893002.
  • 9
    Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 4339.
  • 10
    Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001; 27: 24754.
  • 11
    Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science 2002; 297: 54751.
  • 12
    Cliby WA, Roberts CJ, Cimprich KA et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J 1998; 17: 15969.
  • 13
    O'Driscoll M, Ruiz PV, Woods CG, Jeggo PA, Goodship JA. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet 2003; 33: 497501.
  • 14
    Casper AM, Nghiem P, Arlt MF, Glover TW. ATR regulates fragile site stability. Cell 2002; 111: 77989.
  • 15
    Kagami Y, Nakamura S, Suzuki R et al. Establishment of an IL-2-dependent cell line derived from ‘nasal-type’ NK/T-cell lymphoma of CD2+, sCD3–, CD3epsilon+, CD56+ phenotype and associated with the Epstein–Barr virus. Br J Haematol 1998; 103: 66977.
  • 16
    Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994; 8: 6528.
  • 17
    Nagata H, Konno A, Kimura N et al. Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein–Barr virus. Blood 2001; 97: 70813.
  • 18
    Yodoi J, Teshigawara K, Nikaido T et al. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 1985; 134: 162330.
  • 19
    Yagita M, Huang CL, Umehara H et al. Novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 2000; 14: 92230.
  • 20
    Matsuo Y, Drexler HG, Takeuchi M, Tanaka M, Orita K. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens. Leuk Res 2002; 26: 8739.
  • 21
    Emi N, Abe A, Kasai M et al. CD4- and CD56-positive T-cell line, MTA, established from natural killer-like T-cell leukemia/lymphoma. Int J Hematol 1999; 69: 1805.
  • 22
    Imai S, Sugiura M, Oikawa O et al. Epstein–Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996; 87: 144657.
  • 23
    Liu A, Takakuwa T, Fujita S et al. Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphoma. Lab Invest 2005; 85: 43646.
  • 24
    Abbott DW, Freeman ML, Holt JT. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst 1998; 90: 97885.
  • 25
    Brown EJ, Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev 2000; 14: 397402.
  • 26
    De Klein A, Muijtjens M, Van Os R et al. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr Biol 2000; 10: 47982.
  • 27
    Lewis KA, Mullany S, Thomas B et al. Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance. Cancer Res 2005; 65: 70915.
  • 28
    Teruya-Feldstein J, Jaffe ES, Burd PR et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein–Barr virus-positive lymphoproliferative disease. Blood 1997; 90: 4099105.
  • 29
    Menoyo A, Alazzouzi H, Espin E, Armengol M, Yamamoto H, Schwartz S Jr. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res 2001; 61: 772730.
  • 30
    Vassileva V, Millar A, Briollais L, Chapman W, Bapat B. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. Cancer Res 2002; 62: 40959.
  • 31
    Mongiat-Artus P, Miquel C, Van Der Aa M et al. Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract. Oncogene 2006; 25: 21338.
  • 32
    Li LS, Kim NG, Kim SH et al. Chromosomal imbalances in the colorectal carcinomas with microsatellite instability. Am J Pathol 2003; 163: 142936.
  • 33
    Ham MF, Takakuwa T, Luo WJ et al. Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia–lymphoma cell lines with microsatellite instability. Cancer Sci 2006; 97: 22634.